Skip to main content
Top
Published in: International Journal of Behavioral Medicine 4/2015

01-08-2015

Perceived Barriers and Support Strategies for Reducing Sodium Intake in Patients with Chronic Kidney Disease: a Qualitative Study

Authors: Yvette Meuleman, Lucia ten Brinke, Arjan J. Kwakernaak, Liffert Vogt, Joris I. Rotmans, Willem Jan W. Bos, Paul J. M. van der Boog, Gerjan Navis, Gert A. van Montfrans, Tiny Hoekstra, Friedo W. Dekker, Sandra van Dijk

Published in: International Journal of Behavioral Medicine | Issue 4/2015

Login to get access

Abstract

Background

Reducing sodium intake can prevent cardiovascular complications and further decline of kidney function in patients with chronic kidney disease. However, the vast majority of patients fail to reach an adequate sodium intake, and little is known about why they do not succeed.

Purpose

This study aims to identify perceived barriers and support strategies for reducing sodium intake among both patients with chronic kidney disease and health-care professionals.

Method

A purposive sample of 25 patients and 23 health-care professionals from 4 Dutch medical centers attended 8 focus groups. Transcripts were analyzed thematically and afterwards organized according to the phases of behavior change of self-regulation theory.

Results

Multiple themes emerged across different phases of behavior change, including the patients’ lack of practical knowledge and intrinsic motivation, the maladaptive illness perceptions and refusal skills, the lack of social support and feedback regarding disease progression and sodium intake, and the availability of low-sodium foods.

Conclusions

The results indicate the need for the implementation of support strategies that target specific needs of patients across the whole process of changing and maintaining a low-sodium diet. Special attention should be paid to supporting patients to set sodium-related goals, strengthening intrinsic motivation, providing comprehensive and practical information (e.g., about hidden salt in products), increasing social support, stimulating the self-monitoring of sodium intake and disease progression, and building a supportive patient–professional relationship that encompasses shared decision making and coaching. Moreover, global programs should be implemented to reduce sodium levels in processed foods, introduce sodium-related product labels, and increase consumer awareness.
Literature
1.
go back to reference Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. J Am Med Assoc. 2007;298(17):2038–47.CrossRef Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. J Am Med Assoc. 2007;298(17):2038–47.CrossRef
2.
go back to reference Bosma RJ, Krikken JA, van der Heide JJ H, de Jong PE, Navis GJ. Obesity and renal hemodynamics. Contrib Nephrol. 2006;151:184–202.CrossRefPubMed Bosma RJ, Krikken JA, van der Heide JJ H, de Jong PE, Navis GJ. Obesity and renal hemodynamics. Contrib Nephrol. 2006;151:184–202.CrossRefPubMed
3.
go back to reference Baumeister SE, Böger CA, Krämer BK, Döring A, Eheberg D, Fischer B, et al. Effect of chronic kidney disease and comorbid conditions on health care costs: a 10-year observational study in a general population. Am J Nephrol. 2010;31(3):222–9.CrossRefPubMed Baumeister SE, Böger CA, Krämer BK, Döring A, Eheberg D, Fischer B, et al. Effect of chronic kidney disease and comorbid conditions on health care costs: a 10-year observational study in a general population. Am J Nephrol. 2010;31(3):222–9.CrossRefPubMed
4.
go back to reference De Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker, and a new target for therapy. Kidney Int Suppl. 2005;98:S25–9.CrossRefPubMed De Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker, and a new target for therapy. Kidney Int Suppl. 2005;98:S25–9.CrossRefPubMed
5.
go back to reference Lambers Heerspink HJ, Holtkamp FA, Parving HH, Navis GJ, Lewis JB, Ritz E, et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int. 2012;82(3):330–7.CrossRefPubMed Lambers Heerspink HJ, Holtkamp FA, Parving HH, Navis GJ, Lewis JB, Ritz E, et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int. 2012;82(3):330–7.CrossRefPubMed
6.
go back to reference De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006;69(3):538–45.CrossRefPubMed De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006;69(3):538–45.CrossRefPubMed
7.
go back to reference Suzuki H, Takenaka T, Kanno Y, Ohno Y, Saruta T. Sodium and kidney disease. Contrib Nephrol. 2007;155:90–101.CrossRefPubMed Suzuki H, Takenaka T, Kanno Y, Ohno Y, Saruta T. Sodium and kidney disease. Contrib Nephrol. 2007;155:90–101.CrossRefPubMed
8.
go back to reference Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol. 2008;19(5):999–1007.PubMedCentralCrossRefPubMed Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol. 2008;19(5):999–1007.PubMedCentralCrossRefPubMed
9.
go back to reference Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, et al. Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis. 1995;26(6):934–41.CrossRefPubMed Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, et al. Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis. 1995;26(6):934–41.CrossRefPubMed
10.
go back to reference Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, et al. Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab. 1998;24(4):296–301.CrossRefPubMed Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, et al. Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab. 1998;24(4):296–301.CrossRefPubMed
11.
go back to reference Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012;23(1):165–73.PubMedCentralCrossRefPubMed Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012;23(1):165–73.PubMedCentralCrossRefPubMed
12.
go back to reference Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189–99.PubMedCentralPubMed Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189–99.PubMedCentralPubMed
13.
go back to reference Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol. 2009;38(3):791–813.CrossRefPubMed Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol. 2009;38(3):791–813.CrossRefPubMed
14.
go back to reference Krikken JA, Laverman GD, Navis G. Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr Opin Nephrol Hypertens. 2009;18(6):531–8.CrossRefPubMed Krikken JA, Laverman GD, Navis G. Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr Opin Nephrol Hypertens. 2009;18(6):531–8.CrossRefPubMed
15.
go back to reference Van Zuilen AD, Wetzels JF, Bots ML, Van Blankestijn PJ. MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients. J Nephrol Nurs. 2008;21(3):261–7. Van Zuilen AD, Wetzels JF, Bots ML, Van Blankestijn PJ. MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients. J Nephrol Nurs. 2008;21(3):261–7.
16.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl. 2013;3 (1):1–150. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl. 2013;3 (1):1–150.
17.
go back to reference Kaptein AA, van Dijk S, Broadbent E, Falzon L, Thong M, Dekker FW. Behavioural research in patients with end-stage renal disease: a review and research agenda. Patient Educ Couns. 2010;81(1):23–9.CrossRefPubMed Kaptein AA, van Dijk S, Broadbent E, Falzon L, Thong M, Dekker FW. Behavioural research in patients with end-stage renal disease: a review and research agenda. Patient Educ Couns. 2010;81(1):23–9.CrossRefPubMed
18.
go back to reference Welch JL, Bennett SJ, Delp RL, Agarwal R. Benefits of and barriers to dietary sodium adherence. West J Nurs Res. 2006;28(2):162–80. discussion 181–9.CrossRefPubMed Welch JL, Bennett SJ, Delp RL, Agarwal R. Benefits of and barriers to dietary sodium adherence. West J Nurs Res. 2006;28(2):162–80. discussion 181–9.CrossRefPubMed
19.
go back to reference De Brito-Ashurst I, Perry L, Sanders TAB, Thomas JE, Yaqoob MM, Dobbie H. Barriers and facilitators of dietary sodium restriction amongst Bangladeshi chronic kidney disease patients. J Hum Nutr Diet. 2011;24(1):86–95.CrossRefPubMed De Brito-Ashurst I, Perry L, Sanders TAB, Thomas JE, Yaqoob MM, Dobbie H. Barriers and facilitators of dietary sodium restriction amongst Bangladeshi chronic kidney disease patients. J Hum Nutr Diet. 2011;24(1):86–95.CrossRefPubMed
20.
go back to reference Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. In: Rachman S, editor. Contributions to medical psychology. New York: Pergamon Press; 1980. p. 7–30. Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. In: Rachman S, editor. Contributions to medical psychology. New York: Pergamon Press; 1980. p. 7–30.
21.
go back to reference Leventhal H, Brissette IL. The common-sense model of self-regulation of health and illness. In: Cameron LD, Leventhal HE, editors. The self-regulation of health and illness behaviour. London: Routledge; 2003. p. 42–65. Leventhal H, Brissette IL. The common-sense model of self-regulation of health and illness. In: Cameron LD, Leventhal HE, editors. The self-regulation of health and illness behaviour. London: Routledge; 2003. p. 42–65.
22.
go back to reference Maes S, Karoly P. Self-regulation assessment and intervention in physical health and illness: a review. Appl Psychol. 2005;54(2):267–99.CrossRef Maes S, Karoly P. Self-regulation assessment and intervention in physical health and illness: a review. Appl Psychol. 2005;54(2):267–99.CrossRef
23.
go back to reference Morse JM. The significance of saturation. Qual Health Res. 1995;5(2):147–9.CrossRef Morse JM. The significance of saturation. Qual Health Res. 1995;5(2):147–9.CrossRef
24.
go back to reference Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef
25.
go back to reference Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
26.
go back to reference Curtin RB, Mapes D, Schatell D, Burrows-Hudson S. Self-management in patients with end stage renal disease: exploring domains and dimensions. Nephrol Nurs J. 2005;32(4):389–95.PubMed Curtin RB, Mapes D, Schatell D, Burrows-Hudson S. Self-management in patients with end stage renal disease: exploring domains and dimensions. Nephrol Nurs J. 2005;32(4):389–95.PubMed
27.
go back to reference Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. J Am Med Assoc. 2002;288(19):2469–75.CrossRef Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. J Am Med Assoc. 2002;288(19):2469–75.CrossRef
28.
go back to reference Chen SH, Tsai YF, Sun CY, Wu IW, Lee CC, Wu MS. The impact of self-management support on the progression of chronic kidney disease: a prospective randomized controlled trial. Nephrol Dial Transplant. 2011;26(11):3560–6.CrossRefPubMed Chen SH, Tsai YF, Sun CY, Wu IW, Lee CC, Wu MS. The impact of self-management support on the progression of chronic kidney disease: a prospective randomized controlled trial. Nephrol Dial Transplant. 2011;26(11):3560–6.CrossRefPubMed
29.
go back to reference Wright Nunes JA, Wallston KA, Eden SK, Shintani AK, Ikizler TA, Cavanaugh KL. Associations among perceived and objective disease knowledge and satisfaction with physician communication in patients with chronic kidney disease. Kidney Int. 2011;80(12):1344–51.CrossRefPubMed Wright Nunes JA, Wallston KA, Eden SK, Shintani AK, Ikizler TA, Cavanaugh KL. Associations among perceived and objective disease knowledge and satisfaction with physician communication in patients with chronic kidney disease. Kidney Int. 2011;80(12):1344–51.CrossRefPubMed
30.
go back to reference Safeer RS, Keenan J. Health literacy: the gap between physicians and patients. Am Fam Physician. 2005;72(3):463–8.PubMed Safeer RS, Keenan J. Health literacy: the gap between physicians and patients. Am Fam Physician. 2005;72(3):463–8.PubMed
31.
go back to reference Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826–34.CrossRefPubMed Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826–34.CrossRefPubMed
32.
go back to reference Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–7.CrossRefPubMed Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–7.CrossRefPubMed
33.
go back to reference Chilcot J, Wellsted D, Farrington K. Illness representations are associated with fluid nonadherence among hemodialysis patients. J Psychosom Res. 2010;68(2):203–12.CrossRefPubMed Chilcot J, Wellsted D, Farrington K. Illness representations are associated with fluid nonadherence among hemodialysis patients. J Psychosom Res. 2010;68(2):203–12.CrossRefPubMed
34.
go back to reference O’Connor SM, Jardine AG, Millar K. The prediction of self-care behaviors in end-stage renal disease patients using Leventhal’s self-regulatory model. J Psychosom Res. 2008;65(2):191–200.CrossRefPubMed O’Connor SM, Jardine AG, Millar K. The prediction of self-care behaviors in end-stage renal disease patients using Leventhal’s self-regulatory model. J Psychosom Res. 2008;65(2):191–200.CrossRefPubMed
35.
go back to reference Clark S, Farrington K, Chilcot J. Nonadherence in dialysis patients: prevalence, measurement, outcome, and psychological determinants. Semin Dial. 2014;27(1):42–9.CrossRefPubMed Clark S, Farrington K, Chilcot J. Nonadherence in dialysis patients: prevalence, measurement, outcome, and psychological determinants. Semin Dial. 2014;27(1):42–9.CrossRefPubMed
36.
go back to reference Van Dijk S, Scharloo M, Kaptein AA, Thong MSY, Boeschoten EW, Grootendorst DC, et al. Patients’ representations of their end-stage renal disease: relation with mortality. Nephrol Dial Transplant. 2009;24(10):3183–5.CrossRefPubMed Van Dijk S, Scharloo M, Kaptein AA, Thong MSY, Boeschoten EW, Grootendorst DC, et al. Patients’ representations of their end-stage renal disease: relation with mortality. Nephrol Dial Transplant. 2009;24(10):3183–5.CrossRefPubMed
37.
go back to reference Parfeni M, Nistor I, Covic A. A systematic review regarding the association of illness perception and survival among end-stage renal disease patients. Nephrol Dial Transplant. 2013;28(10):2407–14.CrossRefPubMed Parfeni M, Nistor I, Covic A. A systematic review regarding the association of illness perception and survival among end-stage renal disease patients. Nephrol Dial Transplant. 2013;28(10):2407–14.CrossRefPubMed
38.
go back to reference Rifkin DE, Laws MB, Rao M, Balakrishnan VS, Sarnak MJ, Wilson IB. Medication adherence behavior and priorities among older adults with CKD: a semistructured interview study. Am J Kidney Dis. 2010;56(3):439–46.PubMedCentralCrossRefPubMed Rifkin DE, Laws MB, Rao M, Balakrishnan VS, Sarnak MJ, Wilson IB. Medication adherence behavior and priorities among older adults with CKD: a semistructured interview study. Am J Kidney Dis. 2010;56(3):439–46.PubMedCentralCrossRefPubMed
39.
go back to reference Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens. 2009;11(7):376–82.CrossRef Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens. 2009;11(7):376–82.CrossRef
40.
go back to reference Rollnick S, Miller WR, Butler CC. Motivational interviewing in health care. Helping patients change behavior. New York: Guilford press; 2008. Rollnick S, Miller WR, Butler CC. Motivational interviewing in health care. Helping patients change behavior. New York: Guilford press; 2008.
41.
42.
go back to reference VanBuskirk KA, Wetherell JL. Motivational interviewing with primary care populations: a systematic review and meta-analysis. J Behav Med. 2014;37(4):768–80. VanBuskirk KA, Wetherell JL. Motivational interviewing with primary care populations: a systematic review and meta-analysis. J Behav Med. 2014;37(4):768–80.
43.
go back to reference Murray MA, Brunier G, Chung JO, Craig LA, Mills C, Thomas A, et al. A systematic review of factors influencing decision-making in adults living with chronic kidney disease. Patient Educ Couns. 2009;76(2):149–58.CrossRefPubMed Murray MA, Brunier G, Chung JO, Craig LA, Mills C, Thomas A, et al. A systematic review of factors influencing decision-making in adults living with chronic kidney disease. Patient Educ Couns. 2009;76(2):149–58.CrossRefPubMed
44.
go back to reference Webster JL, Dunford EK, Hawkes C, Neal BC. Salt reduction initiatives around the world. J Hypertens. 2011;29(6):1043–50.CrossRefPubMed Webster JL, Dunford EK, Hawkes C, Neal BC. Salt reduction initiatives around the world. J Hypertens. 2011;29(6):1043–50.CrossRefPubMed
45.
go back to reference Kim MK, Lopetcharat K, Gerard PD, Drake MA. Consumer awareness of salt and sodium reduction and sodium labeling. J Food Sci. 2012;77(9):S307–13.CrossRefPubMed Kim MK, Lopetcharat K, Gerard PD, Drake MA. Consumer awareness of salt and sodium reduction and sodium labeling. J Food Sci. 2012;77(9):S307–13.CrossRefPubMed
46.
go back to reference Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52(1):1–9.CrossRefPubMed Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52(1):1–9.CrossRefPubMed
47.
go back to reference Jaana M, Paré G. Home telemonitoring of patients with diabetes: a systematic assessment of observed effects. J Eval Clin Pract. 2007;13(2):242–53.CrossRefPubMed Jaana M, Paré G. Home telemonitoring of patients with diabetes: a systematic assessment of observed effects. J Eval Clin Pract. 2007;13(2):242–53.CrossRefPubMed
48.
go back to reference Imai Y, Hosaka M, Elnagar N, Satoh M. Clinical significance of home blood pressure measurements for the prevention and management of high blood pressure. Clin Exp Pharmacol Physiol. 2014;41(1):37–45.CrossRefPubMed Imai Y, Hosaka M, Elnagar N, Satoh M. Clinical significance of home blood pressure measurements for the prevention and management of high blood pressure. Clin Exp Pharmacol Physiol. 2014;41(1):37–45.CrossRefPubMed
49.
go back to reference Newson RS, Elmadfa I, Biro G, Cheng Y, Prakash V, Rust P, et al. Barriers for progress in salt reduction in the general population. An international study. Appetite. 2013;71:22–31.CrossRefPubMed Newson RS, Elmadfa I, Biro G, Cheng Y, Prakash V, Rust P, et al. Barriers for progress in salt reduction in the general population. An international study. Appetite. 2013;71:22–31.CrossRefPubMed
50.
go back to reference DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207–18.CrossRefPubMed DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207–18.CrossRefPubMed
51.
go back to reference Gallant MP. The influence of social support on chronic illness self-management: a review and directions for research. Heal Educ Behav. 2003;30(2):170–95.CrossRef Gallant MP. The influence of social support on chronic illness self-management: a review and directions for research. Heal Educ Behav. 2003;30(2):170–95.CrossRef
52.
go back to reference Lindner H, Menzies D, Kelly J, Taylor S, Shearer M. Coaching for behaviour change in chronic disease: a review of the literature and the implications for coaching as a self-management intervention. Aust J Prim Health. 2003;9(3):177–85.CrossRef Lindner H, Menzies D, Kelly J, Taylor S, Shearer M. Coaching for behaviour change in chronic disease: a review of the literature and the implications for coaching as a self-management intervention. Aust J Prim Health. 2003;9(3):177–85.CrossRef
53.
go back to reference Mattes RD, Donnelly D. Relative contributions of dietary sodium sources. J Am Coll Nutr. 1991;10:383–93. Mattes RD, Donnelly D. Relative contributions of dietary sodium sources. J Am Coll Nutr. 1991;10:383–93.
54.
go back to reference Dötsch M, Busch J, Batenburg M, Liem G, Tareilus E, Mueller R, et al. Strategies to reduce sodium consumption: a food industry perspective. Crit Rev Food Sci Nutr. 2009;49(10):841–51.CrossRefPubMed Dötsch M, Busch J, Batenburg M, Liem G, Tareilus E, Mueller R, et al. Strategies to reduce sodium consumption: a food industry perspective. Crit Rev Food Sci Nutr. 2009;49(10):841–51.CrossRefPubMed
Metadata
Title
Perceived Barriers and Support Strategies for Reducing Sodium Intake in Patients with Chronic Kidney Disease: a Qualitative Study
Authors
Yvette Meuleman
Lucia ten Brinke
Arjan J. Kwakernaak
Liffert Vogt
Joris I. Rotmans
Willem Jan W. Bos
Paul J. M. van der Boog
Gerjan Navis
Gert A. van Montfrans
Tiny Hoekstra
Friedo W. Dekker
Sandra van Dijk
Publication date
01-08-2015
Publisher
Springer US
Published in
International Journal of Behavioral Medicine / Issue 4/2015
Print ISSN: 1070-5503
Electronic ISSN: 1532-7558
DOI
https://doi.org/10.1007/s12529-014-9447-x

Other articles of this Issue 4/2015

International Journal of Behavioral Medicine 4/2015 Go to the issue